Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma

Clinical Medicine: Oncology

Volumn 2, Issue , 2008, Pages 169-179

  Lee, Eric H L ^a   Chari, Raj ^a   Lam, Andy ^a   Ng, Raymond T ^a,b   Yee, John ^c   English, John ^c   Evans, Kenneth G ^c   MacAulay, Calum ^a   Lam, Stephen ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Gene expression; Lung cancer; Non canonical; NSCLC; Squamous cell carcinoma; WNT pathway

Indexed keywords

EID: 70449638210     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: 10.4137/cmo.s612     Document Type: Article

References (39)

1. Aust, D.E., Terdiman, J.P., Willenbucher, R.F., Chang, C.G., Molinaro-Clark, A., Baretton, G.B., Loehrs, U. and Waldman, F.M. 2002. ‘The APC/ beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis’. Cancer, 94(5):1421-7.
2. Aznar, S. and Lacal, J.C. 2001. ‘Rho signals to cell growth and apoptosis’. Cancer Lett, 165(1):1-10.
3. Blache, P., van de Wetering, M., Duluc, I., Domon, C., Berta, P., Freund, J.N., Clevers, H. and Jay, P. 2004. ‘SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes’. J. Cell. Biol., 166(1):37-47.
4. Clevers, H. 2006. ‘Wnt/beta-Catenin Signaling in Development and Disease’. Cell., 127(3):469-80.
5. Eberhart, C.G. and Argani, P. 2001. ‘Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage’. Pediatr Dev. Pathol., 4(4):351-7.
6. Feng Han, Q., Zhao, W., Bentel, J., Shearwood, A.M., Zeps, N., Joseph, D., Iacopetta, B. and Dharmarajan, A. 2006. ‘Expression of sFRP-4 and beta-catenin in human colorectal carcinoma’. Cancer Lett, 231(1):129-37.
7. Habas, R., Kato, Y. and He, X. 2001. ‘Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1’. Cell., 107(7):843-54.
8. Hanahan, D. and Weinberg, R.A. 2000. ‘The hallmarks of cancer’. Cell., 100(1):57-70.
9. He, B., You, L., Uematsu, K., Xu, Z., Lee, A.Y., Matsangou, M., McCormick, F. and Jablons, D.M. 2004. ‘A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells’. Neoplasia, 6(1):7-14.
10. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. 1998. ‘Identification of c-MYC as a target of the APC pathway’. Science, 281(5382):1509-12.
11. Hofmann, J. 2004. ‘Protein kinase C isozymes as potential targets for anticancer therapy’. Curr. Cancer Drug Targets, 4(2):125-46.
12. Ilyas, M. 2005. ‘Wnt signalling and the mechanistic basis of tumour development’. J. Pathol., 205(2):130-44.
13. Katoh, M. 2005. ‘WNT/PCP signaling pathway and human cancer (review)’. Oncol. Rep, 14(6):1583-8.
14. Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B. and Clevers, H. 1997. ‘Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma’. Science, 275(5307):1784-7.
15. Kuhl, M., Sheldahl, L.C., Malbon, C.C. and Moon, R.T. 2000. ‘Ca(2K)/ calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus’. J. Biol. Chem., 275(17):12701-11.
16. Liu, W. and Saint, D.A. 2002. ‘A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics’. Anal. Biochem., 302(1):52-9.
17. Lu, D., Zhao, Y., Tawatao, R., Cottam, H.B., Sen, M., Leoni, L.M., Kipps, T.J., Corr, M. and Carson, D.A. 2004. ‘Activation of the Wnt signaling pathway in chronic lymphocytic leukemia’. Proc. Natl. Acad. Sci. U.S.A., 101(9):3118-23.
18. Mann, B., Gelos, M., Siedow, A., Hanski, M.L., Gratchev, A., Ilyas, M., Bodmer, W.F., Moyer, M.P., Riecken, E.O., Buhr, H.J. and Hanski, C. 1999. ‘Target genes of beta-catenin-T cell-factor/lymphoidenhancer- factor signaling in human colorectal carcinomas’. Proc. Natl. Acad. Sci. U.S.A., 96(4):1603-8.
19. Mazieres, J., He, B., You, L., Xu, Z. and Jablons, D.M. 2005. ‘Wnt signaling in lung cancer’. Cancer Lett, 222(1):1-10.
20. Melkonyan, H.S., Chang, W.C., Shapiro, J.P., Mahadevappa, M., Fitzpatrick, P.A., Kiefer, M.C., Tomei, L.D. and Umansky, S.R. 1997. ‘SARPs: a family of secreted apoptosis-related proteins’. Proc. Natl. Acad. Sci. U.S.A., 94(25):13636-41.
21. Minna, J.D., Roth, J.A. and Gazdar, A.F. 2002. ‘Focus on lung cancer’. Cancer Cell., 1(1):49-52.
22. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. 1997. ‘Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC’. Science, 275(5307):1787-90.
23. Ohira, T., Gemmill, R.M., Ferguson, K., Kusy, S., Roche, J., Brambilla, E., Zeng, C., Baron, A., Bemis, L., Erickson, P., Wilder, E., Rustgi, A., Kitajewski, J., Gabrielson, E., Bremnes, R., Franklin, W. and Drabkin, H.A. 2003. ‘WNT7a induces E-cadherin in lung cancer cells’. Proc. Natl. Acad. Sci. U.S.A., 100(18):10429-34.
24. Pongracz, J.E. and Stockley, R.A. 2006. ‘Wnt signalling in lung development and diseases’. Respir. Res., 7(15).
25. Schumann, H., Holtz, J., Zerkowski, H.R. and Hatzfeld, M. 2000. ‘Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression’. Cardiovasc. Res., 45(3):720-8.
26. Sheldahl, L.C., Park, M., Malbon, C.C. and Moon, R.T. 1999. ‘Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner’. Curr. Biol., 9(13):695-8.
27. Shigemitsu, K., Sekido, Y., Usami, N., Mori, S., Sato, M., Horio, Y., Hasegawa, Y., Bader, S.A., Gazdar, A.F., Minna, J.D., Hida, T., Yoshioka, H., Imaizumi, M., Ueda, Y., Takahashi, M. and Shimokata, K. 2001. ‘Genetic alteration of the beta-catenin gene (CTNNB.1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion’. Oncogene., 20(31):4249-57.
28. Slusarski, D.C., Corces, V.G. and Moon, R.T. 1997. ‘Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling’. Nature, 390(6658):410-3.
29. Steel, M.D., Puddicombe, S.M., Hamilton, L.M., Powell, R.M., Holloway, J.W., Holgate, S.T., Davies, D.E. and Collins, J.E. 2005. ‘Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells’. Int. J. Biochem. Cell. Biol., 37(6):1281-95.
30. Suzuki, H., Watkins, D.N., Jair, K.W., Schuebel, K.E., Markowitz, S.D., Chen, W.D., Pretlow, T.P., Yang, B., Akiyama, Y., Van Engeland, M., Toyota, M., Tokino, T., Hinoda, Y., Imai, K., Herman, J.G. and Baylin, S.B. 2004. ‘Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer’. Nat. Genet., 36(4):417-22.
31. Taniguchi, K., Roberts, L.R., Aderca, I.N., Dong, X., Qian, C., Murphy, L.M., Nagorney, D.M., Burgart, L.J., Roche, P.C., Smith, D.I., Ross, J.A. and Liu, W. 2002. ‘Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas’. Oncogene., 21(31):4863-71.
32. Tapper, J., Kettunen, E., El-Rifai, W., Seppala, M., Andersson, L.C. and Knuutila, S. 2001. ‘Changes in gene expression during progression of ovarian carcinoma’. Cancer Genet. Cytogenet, 128(1):1-6.
33. Torres, M.A., Yang-Snyder, J.A., Purcell, S.M., DeMarais, A.A., McGrew, L.L. and Moon, R.T. 1996. ‘Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development’. J. Cell. Biol., 133:1123-37.
34. Ueda, M., Gemmill, R.M., West, J., Winn, R., Sugita, M., Tanaka, N., Ueki, M. and Drabkin, H.A. 2001. ‘Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas’. Br. J. Cancer, 85(1):64-8.
35. Uematsu, K., He, B., You, L., Xu, Z., McCormick, F. and Jablons, D.M. 2003. ‘Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression’. Oncogene, 22(46):7218-21.
36. Veeman, M.T., Axelrod, J.D. and Moon, R.T. 2003. ‘A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling’. Dev. Cell., 5(3):367-77.
37. Weksberg, R., Hughes, S., Moldovan, L., Bassett, A.S., Chow, E.W. and Squire, J.A. 2005. ‘A method for accurate detection of genomic microdeletions using real-time quantitative PCR’. BMC Genomics, 6(180).
38. Winn, R.A., Marek, L., Han, S.Y., Rodriguez, K., Rodriguez, N., Hammond, M., Van Scoyk, M., Acosta, H., Mirus, J., Barry, N., Bren-Mattison, Y., Van Raay, T.J., Nemenoff, R.A. and Heasley, L.E. 2005. ‘Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation’. J. Biol. Chem., 280:19625-34.
39. You, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Mikami, I., Reguart, N., Moody, T.W., Kitajewski, J., McCormick, F and Jablons, D.M. 2004. ‘Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells’. Oncogene, 23(36):6170-4.